Coronary Artery Disease Clinical Trials in New York, New York

21 studies are recruiting for coronary artery disease in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Product Surveillance Registry

    The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

    Stage
    Not phased
    Ages
    Any age
    Site
    Research site, New York, New York
    Locations
    401 in total
    Run by
    Medtronic
  2. Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

    This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasibility of the percutaneous endovascular catheter-facilitated intramyocardial delivery of XC001 in patients with RA due to obstructive CAD. Pa…

    Stage
    Phase 2
    Ages
    18 to 85
    Site
    Weill Cornell Medicine, New York, New York
    Locations
    14 in total
    Run by
    XyloCor Therapeutics, Inc.
  3. Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

    The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients will be randomized to undergo HRPCI with either the Supira System (investigational device) or the commercia…

    Stage
    Not phased
    Ages
    18 to 90
    Site
    Cuimc/Nyph, New York, New York
    Locations
    19 in total
    Run by
    Supira Medical
  4. REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

    This is a research study in women to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is an o…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Icahn School of Medicine - Mount Sinai Morningside, New York, New York
    Locations
    18 in total
    Run by
    Weill Medical College of Cornell University
  5. REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

    This is a research study in minorities to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Icahn School of Medicine - Mount Sinai Morningside, New York, New York
    Locations
    18 in total
    Run by
    Weill Medical College of Cornell University
  6. A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)

    The OPTIMAL randomized clinical trial has been designed to compare two imaging strategies and to test the hypothesis that a calcium modification strategy informed by coronary CT angiography (CCTA) will improve procedural efficiency and effectiveness compared with the current standard of care (IVUS-…

    Stage
    Not phased
    Ages
    18 to 85
    Site
    Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York
    Locations
    14 in total
    Run by
    Fundación EPIC
  7. Randomization of Single vs Multiple Arterial Grafts

    The primary hypothesis of ROMA is that in patients undergoing primary isolated non-emergent coronary artery bypass surgery (CABG), the use of two or more arterial grafts compared to a single arterial graft is associated with a reduction in the composite outcome of death from any cause, any stroke, …

    Stage
    Not phased
    Ages
    18 to 70
    Site
    Icahn School of Medicine, Mount Sinai, New York, New York
    Locations
    59 in total
    Run by
    Weill Medical College of Cornell University
  8. Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

    Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiate…

    Stage
    Not phased
    Ages
    Any age
    Site
    Columbia University, New York, New York
    Locations
    48 in total
    Run by
    Minneapolis Heart Institute Foundation
  9. Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

    The purpose of the study is to assess the safety and efficacy of the Orsiro® Mission 48- mm Sirolimus-Eluting Coronary Stent System in the treatment of subjects with atherosclerotic lesion(s) >36 mm and ≤ 44 mm in length (by visual estimate) in the native coronary arteries with a reference vessel d…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Columbia University Irving Medical Center/New York Presbyterian Hospital, New York, New York
    Locations
    23 in total
    Run by
    Teleflex
  10. SELUTION 4 De Novo Small Vessel IDE Trial

    Prospective, randomized controlled, single-blind, multicenter, clinical trial to demonstrate the safety and efficacy of the SELUTION SLR 014 PTCA DEB for treatment of de novo lesions in small coronary vessels, defined as reference vessel diameter (RVD) of 2.00 mm to 2.75 mm, in support of a pre-mar…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Icahn School of Medicine at Mount Sinai, New York, New York
    Locations
    70 in total
    Run by
    M.A. Med Alliance S.A.
  11. Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment

    The NODULE-SHOCK trial is a prospective, investigator-initiated, single-center, randomized controlled trial designed to compare the efficacy of intravascular lithotripsy (IVL) with or without rotational atherectomy (RA) in patients with coronary calcified nodules (Cohort A), and operator-determined…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Mount Sinai Hospital, New York, New York
    Run by
    Annapoorna Kini
  12. ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

    The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.

    Stage
    Not phased
    Ages
    18 and older
    Site
    The Mount Sinai Hospital, New York, New York
    Locations
    19 in total
    Run by
    Emory University
  13. CTSN Embolic Protection Trial

    This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.

    Stage
    Not phased
    Ages
    60 and older
    Site
    Columbia University Medical Center, New York, New York
    Locations
    28 in total
    Run by
    Icahn School of Medicine at Mount Sinai
  14. Prevail Global Study

    The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Cumc/Nyph, New York, New York
    Locations
    51 in total
    Run by
    Medtronic Vascular
  15. The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial

    Heart disease remains the leading cause of death in Veterans. Inflammation in the arteries of the heart may increase the risk of cardiac death. Patients with heart disease undergoing major surgery are at increased risk of complications after surgery, including heart attack, stroke, and death. The p…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    VA NY Harbor Healthcare System, New York, NY, New York, New York
    Locations
    9 in total
    Run by
    VA Office of Research and Development
  16. Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

    The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and c…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Weill Cornell Medicine, New York, New York
    Locations
    146 in total
    Run by
    Weill Medical College of Cornell University
  17. MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

    This is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic TouchTM Drug coated ba…

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Icahn School of Medicine at Mount Sinai/ Mount Sinai Hospital, New York, New York
    Locations
    24 in total
    Run by
    Concept Medical Inc.
  18. Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

    Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…

    Stage
    Not phased
    Ages
    Any age
    Site
    Mount Sinai, New York, New York
    Locations
    72 in total
    Run by
    University of British Columbia
  19. Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

    COMPLETE-2 is a prospective, multi-centre, randomized controlled trial comparing a strategy of physiology-guided complete revascularization to angiography-guided complete revascularization in patients with acute ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardi…

    Stage
    Not phased
    Ages
    18 and older
    Site
    VA New York Harbor HealthCare System, New York, New York
    Locations
    113 in total
    Run by
    Population Health Research Institute
  20. PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

    This purpose of this trial is to demonstrate 30 day safety and effectiveness outcomes of the KARDION CORY P4 System in subjects who require hemodynamic support during a high-risk PCI procedure.

    Stage
    Not phased
    Ages
    18 to 90
    Site
    Mount Sinai, New York, New York
    Locations
    18 in total
    Run by
    Kardion Inc
  21. MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

    A Prospective, Multicenter, Randomized, Two-Arm, Single-blind Superiority Trial to Evaluate the Safety and Efficacy of the MagicTouch™ Sirolimus- Coated Balloon in the Treatment of Coronary Drug-Eluting Stent In-Stent Restenosis. Subjects with prior DES implantation presenting with ISR lesions unde…

    Stage
    Not phased
    Ages
    18 to 110
    Site
    VA New York Harbor Healthcare System, New York, New York
    Locations
    28 in total
    Run by
    Concept Medical Inc.

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.